MUCORA THERAPEUTICS LTD
Significant control: Mark Edward Brimble (significant control), David Martyn Fleet (significant control) and 2 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Mucora Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Mucora Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MUCORA THERAPEUTICS LTD is an active private limited company (company number 13169210) incorporated on 1 February 2021, registered in Salisbury. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 28 February 2026, showing net assets of £532k and cash of £416k, with 1 employee on average. Net assets fell 55% on the prior period (£1.17m). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the top quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
Ownership and control
- Mark Edward Brimble
- has significant influence or control
- Mr David Martyn Fleet
- has significant influence or control
- Joanne Collett
- has significant influence or control
- Mr Joshua Fleet
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 1 February 20215 yrs ago
- Next accounts due
- 28 November 2027in 396 days
- Confirmation statement due
- 15 February 2027in 110 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2026 | £532k | £416k | £142k | — | — | — | 1 |
| 28 February 2025 | £1.17m | £1.08m | £84 | — | — | — | 1 |
| 29 February 2024 | £1.49m | £1.43m | £6,518 | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £531,844 at 28 February 2026
- Net assets down 25% or more on the prior period-54.7% vs prior period
- Cash at bank of £50,000 or moreCash £415,589
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 1 February 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 396 days
- Confirmation statement duein 110 days
- Accounts period endNet assets £532k · small accounts
- Accounts period endNet assets £1.17m · small accounts
- Accounts period endNet assets £1.49m · small accounts
- Incorporated
Similar companies in the UK
- CONTINUUM RESEARCH HOLDINGS LIMITEDHereford · inc. Feb 2021
- ACTIFRAME LIMITEDSt. Andrews · inc. Feb 2021
- VOR PHARMA LTDTewkesbury · inc. Feb 2021
- QUALITY ELEMENT LTDGordon · inc. Jan 2021
- CITY FARM SYSTEMS (CHINA) LTDHigh Wycombe · inc. Feb 2021
- IDEALOGIX LIMITEDScarborough · inc. Mar 2021
All companies incorporated on 1 February 2021 · in Feb 2021.
Reminders for MUCORA THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.